Found 10 matching trials
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
PHASE3The primary hypothesis being tested in this trial is that ischemic stroke p...
Location
Multiple Locations
Pro-urokinase for Extended-Window Posterior Circulation Stroke
PHASE3This study aims to evaluate whether, in patients with imaging-confirmed acu...
Location
Department of Neurology, the First Affiliated Hospital of Zhengzhou University
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
PHASE3The purpose of this study is to investigate the safety and efficacy of rhPr...
Location
Taihe Hospital of Traditional Chinese Medicine
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
PHASE3This randomized, double-blind, placebo-controlled phase III clinical trial ...
Location
The First Hospital of Lanzhou University
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
PHASE4Minor stroke is considered an acute ischemic stroke (AIS) that has a Nation...
Location
Second Affiliated Hospital of Zhejiang University, School of Medicine
Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
PHASE3The HOPE-MeVO study aims to evaluate the efficacy and safety of intravenous...
Location
The First Affiliated Hospital of Anhui Medical University
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
PHASE2This trial is being conducted to assess the efficacy and safety of recombin...
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
PHASE3The primary hypothesis being tested in this trial is that ischemic stroke p...
Location
Multiple Locations
Real-World Evaluation of Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours
N/AAcute ischemic stroke is a major cause of disability and death. Intravenous...
Location
The First Affiliated Hospital of Anhui Medical University
Intravenous Thrombolysis and NOAC
PHASE3New oral anticoagulants (NOACs), including rivaroxaban, apixaban, dabigatra...
Location
Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou